Article ID Journal Published Year Pages File Type
3390740 Rheumatic Disease Clinics of North America 2008 9 Pages PDF
Abstract
B-cell hyperactivity has been recognized for a long time in Sjögren's syndrome. This B-cell activation is firstly polyclonal but can progress to monoclonal B-cell lymphoproliferation. This article addresses the therapeutic potential of B-cell modulation in Sjögren's syndrome.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Immunology, Allergology and Rheumatology
Preview
Therapeutic Potential for B-Cell Modulation in Sjögren's Syndrome
Authors
, ,